| Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study B Schurink, E Roos, T Radonic, E Barbe, CSC Bouman, HH de Boer, ... The Lancet Microbe 1 (7), e290-e299, 2020 | 556 | 2020 |
| Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial RJS Coelen, E Roos, JK Wiggers, MG Besselink, CI Buis, ORC Busch, ... The lancet Gastroenterology & hepatology 3 (10), 681-690, 2018 | 196 | 2018 |
| Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience F Rassam, E Roos, KP Van Lienden, JE Van Hooft, HJ Klümpen, ... Langenbeck's archives of surgery 403, 289-307, 2018 | 138 | 2018 |
| Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: a systematic review and meta-analysis LC Franken, AM Schreuder, E Roos, S van Dieren, OR Busch, ... Surgery 165 (5), 918-928, 2019 | 122 | 2019 |
| Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma M Strijker, EC Soer, M de Pastena, A Creemers, A Balduzzi, JJ Beagan, ... International journal of cancer 146 (5), 1445-1456, 2020 | 93 | 2020 |
| Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours RJ Molenaar, RJS Coelen, M Khurshed, E Roos, MWA Caan, ... BMJ open 7 (6), e014961, 2017 | 87 | 2017 |
| IgG4-associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience E Roos, LM Hubers, RJS Coelen, ME Doorenspleet, N de Vries, J Verheij, ... Official journal of the American College of Gastroenterology| ACG 113 (5 …, 2018 | 66 | 2018 |
| Detection and localization of early-and late-stage cancers using platelet RNA S GJG, M Arkani, E Post, M Antunes-Ferreira, S D’Ambrosi, DCL Vessies, ... Cancer Cell 40 (9), 999-1009. e6, 2022 | 63 | 2022 |
| Brain inflammation and intracellular α-synuclein aggregates in macaques after SARS-CoV-2 infection IH Philippens, KP Böszörményi, JAM Wubben, ZC Fagrouch, N van Driel, ... Viruses 14 (4), 776, 2022 | 48 | 2022 |
| Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 1: e290–e299 B Schurink, E Roos, T Radonic, E Barbe, CSC Bouman, HH de Boer, ... | 46 | 2020 |
| Indoleamine 2, 3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19 L Guo, B Schurink, E Roos, EJ Nossent, JW Duitman, APJ Vlaar, ... The Journal of pathology 256 (3), 256-261, 2022 | 40 | 2022 |
| Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases S Buettner, JLA van Vugt, MP Gaspersz, RJS Coelen, E Roos, TA Labeur, ... HPB 19 (8), 735-740, 2017 | 40 | 2017 |
| SARS-CoV-2 causes brain inflammation and induces Lewy body formation in macaques IH Philippens, KP Böszörményi, JA Wubben, ZC Fagrouch, N van Driel, ... BioRxiv, 2021.02. 23.432474, 2021 | 35 | 2021 |
| Eligibility for liver transplantation in patients with perihilar cholangiocarcinoma JJA Vugts, MP Gaspersz, E Roos, LC Franken, PB Olthof, RJS Coelen, ... Annals of surgical oncology 28, 1483-1492, 2021 | 30 | 2021 |
| COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography A Kianzad, LJ Meijboom, EJ Nossent, E Roos, B Schurink, PI Bonta, ... Respirology 26 (9), 869-877, 2021 | 29 | 2021 |
| Lost in translation: confusion on resection and dissection planes hampers the interpretation of pathology reports for perihilar cholangiocarcinoma E Roos, LC Franken, EC Soer, JE van Hooft, RB Takkenberg, ... Virchows Archiv 475, 435-443, 2019 | 29 | 2019 |
| Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review LC Franken, MJ van der Poel, AEJ Latenstein, MJ Zwart, E Roos, ... Journal of robotic surgery 13, 717-727, 2019 | 27 | 2019 |
| Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol RJS Coelen, JA Vogel, LGPH Vroomen, E Roos, ORC Busch, ... BMJ open 7 (9), e015810, 2017 | 27 | 2017 |
| Crossing borders: a systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract E Roos, EC Soer, S Klompmaker, LL Meijer, MG Besselink, E Giovannetti, ... Critical reviews in oncology/hematology 140, 8-16, 2019 | 25 | 2019 |
| Prognosis of primary and recurrent chondrosarcoma of the rib E Roos, F van Coevorden, C Verhoef, MW Wouters, HM Kroon, ... Annals of surgical oncology 23, 811-817, 2016 | 25 | 2016 |
